181 related articles for article (PubMed ID: 1333822)
1. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
Del Bino G; Bruno S; Yi PN; Darzynkiewicz Z
Cell Prolif; 1992 Nov; 25(6):537-48. PubMed ID: 1333822
[TBL] [Abstract][Full Text] [Related]
2. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
Del Bino G; Skierski JS; Darzynkiewicz Z
Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
Del Bino G; Darzynkiewicz Z
Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
[TBL] [Abstract][Full Text] [Related]
5. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
Bruno S; Giaretti W; Darzynkiewicz Z
J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
Gorczyca W; Melamed MR; Darzynkiewicz Z
Toxicol Lett; 1993 Apr; 67(1-3):249-58. PubMed ID: 8383887
[TBL] [Abstract][Full Text] [Related]
7. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
Del Bino G; Skierski JS; Darzynkiewicz Z
Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279
[TBL] [Abstract][Full Text] [Related]
8. A new action for topoisomerase inhibitors.
Zucker RM; Elstein KH
Chem Biol Interact; 1991; 79(1):31-40. PubMed ID: 1647887
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Bertrand R; Solary E; Jenkins J; Pommier Y
Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
[TBL] [Abstract][Full Text] [Related]
10. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.
Inaba M; Mitsuhashi J; Kawada S; Nakano H
Jpn J Cancer Res; 1994 Feb; 85(2):187-93. PubMed ID: 8144400
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.
Bruno S; Lassota P; Giaretti W; Darzynkiewicz Z
Oncol Res; 1992; 4(1):29-35. PubMed ID: 1374671
[TBL] [Abstract][Full Text] [Related]
12. Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessment.
Zucker RM; Adams DJ; Bair KW; Elstein KH
Biochem Pharmacol; 1991 Nov; 42(11):2199-208. PubMed ID: 1659821
[TBL] [Abstract][Full Text] [Related]
13. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z
Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962
[TBL] [Abstract][Full Text] [Related]
14. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
[TBL] [Abstract][Full Text] [Related]
15. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
[TBL] [Abstract][Full Text] [Related]
16. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
Del Bino G; Li X; Traganos F; Darzynkiewicz Z
Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535
[TBL] [Abstract][Full Text] [Related]
17. Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation.
Hotz MA; Traganos F; Darzynkiewicz Z
Exp Cell Res; 1992 Jul; 201(1):184-91. PubMed ID: 1319346
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
Gong J; Li X; Darzynkiewicz Z
J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159
[TBL] [Abstract][Full Text] [Related]
19. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
Roberge M; Th'ng J; Hamaguchi J; Bradbury EM
J Cell Biol; 1990 Nov; 111(5 Pt 1):1753-62. PubMed ID: 2172257
[TBL] [Abstract][Full Text] [Related]
20. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
Aldridge DR; Radford IR
Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
